OSR Health Statistics
Total Valuation
OSR Health has a market cap or net worth of $11.73 million. The enterprise value is $15.11 million.
| Market Cap | 11.73M |
| Enterprise Value | 15.11M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OSR Health has 35.10 million shares outstanding. The number of shares has increased by 607.51% in one year.
| Current Share Class | 35.10M |
| Shares Outstanding | 35.10M |
| Shares Change (YoY) | +607.51% |
| Shares Change (QoQ) | +20.36% |
| Owned by Insiders (%) | 19.43% |
| Owned by Institutions (%) | 0.95% |
| Float | 14.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.46 |
| Forward PS | 5.02 |
| PB Ratio | 0.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.16 |
| Quick Ratio | 0.11 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.63 |
Financial Efficiency
Return on equity (ROE) is -14.74% and return on invested capital (ROIC) is -14.65%.
| Return on Equity (ROE) | -14.74% |
| Return on Assets (ROA) | -6.88% |
| Return on Invested Capital (ROIC) | -14.65% |
| Return on Capital Employed (ROCE) | -12.37% |
| Weighted Average Cost of Capital (WACC) | 7.83% |
| Revenue Per Employee | $119,481 |
| Profits Per Employee | -$434,070 |
| Employee Count | 22 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 3.47 |
Taxes
| Income Tax | -2.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.28% in the last 52 weeks. The beta is 0.61, so OSR Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -73.28% |
| 50-Day Moving Average | 0.50 |
| 200-Day Moving Average | 0.56 |
| Relative Strength Index (RSI) | 34.14 |
| Average Volume (20 Days) | 903,044 |
Short Selling Information
The latest short interest is 1.43 million, so 4.06% of the outstanding shares have been sold short.
| Short Interest | 1.43M |
| Short Previous Month | 1.18M |
| Short % of Shares Out | 4.06% |
| Short % of Float | 9.72% |
| Short Ratio (days to cover) | 1.27 |
Income Statement
In the last 12 months, OSR Health had revenue of $2.63 million and -$9.55 million in losses. Loss per share was -$0.39.
| Revenue | 2.63M |
| Gross Profit | 548,150 |
| Operating Income | -19.09M |
| Pretax Income | -21.42M |
| Net Income | -9.55M |
| EBITDA | -9.63M |
| EBIT | -19.09M |
| Loss Per Share | -$0.39 |
Balance Sheet
The company has $1.57 million in cash and $4.95 million in debt, with a net cash position of -$3.39 million or -$0.10 per share.
| Cash & Cash Equivalents | 1.57M |
| Total Debt | 4.95M |
| Net Cash | -3.39M |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 127.39M |
| Book Value Per Share | 3.12 |
| Working Capital | -14.97M |
Cash Flow
In the last 12 months, operating cash flow was -$5.27 million and capital expenditures -$176,385, giving a free cash flow of -$5.44 million.
| Operating Cash Flow | -5.27M |
| Capital Expenditures | -176,385 |
| Depreciation & Amortization | 9.46M |
| Net Borrowing | 3.52M |
| Free Cash Flow | -5.44M |
| FCF Per Share | -$0.16 |
Margins
| Gross Margin | 20.85% |
| Operating Margin | -726.07% |
| Pretax Margin | -814.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OSR Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -607.51% |
| Shareholder Yield | -607.51% |
| Earnings Yield | -81.45% |
| FCF Yield | -46.42% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 119.43% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OSR Health has an Altman Z-Score of -0.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.54 |
| Piotroski F-Score | 2 |